4D Molecular Therapeutics revenue was $14.13 m in FY, 2018 which is a 144% year over year increase from the previous period.
4D Molecular Therapeutics revenue breakdown by business segment: 63.6% from Collaboration and Research Revenue (Related Parties) and 36.4% from Collaboration and Research Revenue
|FY, 2017||FY, 2018|
|Collaboration and Research Revenue (Related Parties)||2.61 m||8.99 m|
|Collaboration and Research Revenue||3.18 m||5.14 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.